Table of Contents Author Guidelines Submit a Manuscript
Autism Research and Treatment
Volume 2012, Article ID 679801, 14 pages
http://dx.doi.org/10.1155/2012/679801
Clinical Study

IGF1 as a Potential Treatment for Rett Syndrome: Safety Assessment in Six Rett Patients

1Tuscany Rett Center, Versilia Hospital, 55043 Lido di Camaiore, Italy
2Neurology Division, Versilia Hospital, 55043 Lido di Camaiore, Italy
3Department of Neurology, University of Pisa, 56126 Pisa, Italy
4Trinity College Institute for Neuroscience, College Green, Dublin 2, Ireland
5School of Medicine and CRANN, Trinity College Dublin, College Green, Dublin 2, Ireland
6Department of Psychiatry, Neuropsychiatric Genetics Research Group, Trinity Center for Health Sciences, St James Hospital, Dublin 8, Ireland
7Department of Brain and Cognitive Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA

Received 2 February 2012; Accepted 3 April 2012

Academic Editor: Louise Gallagher

Copyright © 2012 Giorgio Pini et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Giorgio Pini, Maria Flora Scusa, Laura Congiu, et al., “IGF1 as a Potential Treatment for Rett Syndrome: Safety Assessment in Six Rett Patients,” Autism Research and Treatment, vol. 2012, Article ID 679801, 14 pages, 2012. https://doi.org/10.1155/2012/679801.